December 27, 2017 by Brian McDonagh, Gregg Lipman and Chain Drug Review
Aetna, Brian McDonagh, CBX, CVS Health, CVS-Aetna deal, CVS-Aetna merger, Gregg Lipman, MinuteClinic
2018, Issue 01-01-2018, Issues, Leading Headlines, Opinion
The pending $69 billion acquisition of Aetna by CVS could yield valuable lessons for others in the health care and drugstore sectors as they seek to forge stronger ties to consumers. What interests us here is the potential for the CVS-Aetna merger to create new, meaningfully differentiated brand experiences for consumers. CVS has nearly 10,000
December 14, 2017 by CDR Blog and Chain Drug Review
Amazon, Brian Tanquilut, CVS-Aetna merger, FedEx, Jefferies, Walgreens Boots Alliance
CDR Blog
A CVS-Aetna merger or not, Walgreens Boots Alliance is zeroed in and making headway on its strategic game plan, according to Jefferies analyst Brian Tanquilut. Following a visit to WBA’s headquarters in Deerfield, Ill., last week by the Jefferies team, Tanquilut reported that the CVS deal didn’t “prompt a kneejerk reaction,” and WBA executives remain
December 14, 2017 by Chain Drug Review
CVS Health, CVS Pharmacy, CVS-Aetna merger, Larry Merlo, National Public Radio, NPR, Steve Inskeep
Featured Articles, Leading Headlines, Pharmacy, Retail News
NEW YORK — Acquiring Aetna Inc. will better position CVS Health to improve health outcomes and bring affordable health care to more Americans, CVS president and chief executive officer Larry Merlo told National Public Radio (NPR). The addition of a health insurer like Aetna will allow CVS to provide a more comprehensive care offering to
December 11, 2017 by Bill Schiffner
Aetna, Amazon, Brian Tanquilut, CVS Health, CVS Pharmacy, CVS-Aetna merger, Jefferies, Larry Merlo, Mark Bertolini, MinuteClinic
2017, Issue 12-11-2017, Issues, News
WOONSOCKET, R.I. — CVS Health plans to acquire health insurer Aetna for roughly $69 billion in a first-of-its kind deal aimed at fending off challenges in retail and health care. The landmark CVS-Aetna merger deal comes at time when insurers are under pressure to lower medical costs, and retailers are under attack from new competitors,
December 5, 2017 by CDR Blog and Chain Drug Review
Bruce Carlson, CVS Health, CVS-Aetna merger, in-store health clinic, Kalorama Information, MinuteClinic, retail clinic market, Retail Clinics 2017: The Game-Changer in Healthcare, walk-in medical clinic
CDR Blog
While the changes that CVS Health’s $69 billion deal to buy Aetna may bring to the health care sector remain unclear, it’s very likely that a big beneficiary of deal would be MinuteClinic, says one market researcher. “Now these retail clinics in effect become in-house health care providers for Aetna,” explained Bruce Carlson, publisher at
December 3, 2017 by Chain Drug Review
Aetna, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna merger, Larry Merlo, Mark Bertolini, MinuteClinic
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I., and HARTFORD, Conn. — Following mounting speculation over the past month, CVS Health has unveiled a cash-and stock-deal to acquire health insurer Aetna Inc. for $69 billion. CVS and Aetna said Sunday evening that under the merger pact, Aetna shareholders will receive about $207 per share, including $145 in cash and 0.8378 CVS
November 20, 2017 by Chain Drug Review
Aetna, Amazon, CVS Health, CVS-Aetna merger, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — A deal for CVS Health to acquire Aetna Inc. could happen by the end of the month, published reports say. Citing anonymous sources, The Wall Street Journal reported Monday that CVS was nearing a $66 billion agreement to buy the health insurer, according to reports. The news of a potential CVS-Aetna merger